International Journal of Molecular Medicine and Advance Sciences (IJMMAS) — ISSN Print: 1813-176x  ISSN Online: 1994-4624 — is an international, peer-reviewed, open-access scientific journal committed to advancing knowledge in molecular medicine, biomedical sciences, genetics, biotechnology, and related interdisciplinary fields. The journal serves as a global platform for researchers, clinicians, academicians, and healthcare professionals to publish high-quality research that contributes to scientific innovation and improved healthcare outcomes.

IJMMAS is published by MAK Hill Publication and carries ISSN: 1813-176X and eISSN: 1994-4624. The journal is supported by a dedicated Editorial Board and Editorial Team comprising qualified academics, researchers, and subject experts, who oversee the editorial and peer-review processes and work to maintain the scientific quality, academic integrity, and ethical standards of the journal.

IJMMAS is dedicated to promoting excellence in scientific publishing by ensuring that manuscripts undergo rigorous editorial assessment and independent double-blind peer review. Editorial decisions are based on scientific merit, originality, methodological quality, ethical compliance, and relevance to the journal's scope. The Editorial Team monitors the editorial workflow and supports consistent application of peer-review and publication standards.

The journal welcomes a wide range of scholarly contributions, including Original Research Articles, Review Articles, Systematic Reviews, Meta-Analyses, Short Communications, Case Reports, Clinical Studies, Technical Notes, Editorials, Perspectives, and Letters to the Editor. Manuscripts from both basic and translational research are encouraged, particularly those that bridge laboratory discoveries with clinical applications.

The journal is committed to maintaining high standards of research integrity, transparency, publication ethics, originality, and methodological soundness. Authors, reviewers, editors, and editorial staff are expected to follow internationally recognized principles of responsible scholarly publishing. IJMMAS follows relevant recommendations of organizations such as ICMJE and COPE in its editorial and publication practices.

As an open-access journal, IJMMAS aims to make published scholarly work freely accessible to the global research community, facilitating the dissemination of scientific knowledge and encouraging collaboration among researchers, clinicians, and healthcare professionals worldwide.

The mission of the International Journal of Molecular Medicine and Advance Sciences is to accelerate scientific discovery by publishing innovative, evidence-based, and ethically conducted research that contributes to advances in molecular medicine, biomedical sciences, healthcare, and related life sciences. The journal strives to foster international collaboration and provide a reliable platform for the communication of meaningful scientific discoveries.